Sonia Appel
Founder Alismere
Sonia Appel has led biotech technical operations for over 20 years, from early pharmaceutical development to commercial molecular diagnostics. She has run multiple scale-up and portfolio expansion projects, successful CMC programs, and placed small molecules and ADCs in the clinic. She is the founder of alismereTM life sciences, a consulting firm partnering with biotech technical operations C-level to create frameworks and develop strategies that drive the execution of technical programs of any complexity.
Seminars
- Leveraging resources to sustain early manufacturability assessments
- Promoting communication and stakeholder engagement between manufacturing and discovery teams to uncover golden opportunities
- Shortening ADC manufacturing timelines without increasing associated risk
Identifying, selecting and maintaining strong relationships with external manufacturing partners is vital to navigate the complex global ADC supply chain, often with multiple CMO partners whilst under accelerated ADC development timelines
Join this strategy-led workshop to navigate selection criteria and best practices to ensure beneficial relationships with outsourcing partners and de-risk your ADC manufacturing and supply
Workshop highlights include:
- Discussing opportunities to establish and maintain effective collaboration between sponsor companies and CMOs
- Breaking down criteria considerations to assess and prioritise manufacturing partner selection
- Assessing challenges in ADC drug-linker manufacturing and supply to understand key risk factors and deploy best strategies for mitigation management
